Skip to main content

Market Overview

28 Healthcare Stocks Moving In Friday's Pre-Market Session

Share:

Gainers

  • TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) shares increased by 49.8% to $3.73 during Friday's pre-market session. The market value of their outstanding shares is at $12.3 million.
  • Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) stock surged 10.0% to $1.65. The market cap stands at $71.1 million. The most recent rating by Oppenheimer, on December 20, is at Outperform, with a price target of $6.00.
  • Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) stock moved upwards by 9.0% to $4.83. The market cap seems to be at $394.2 million. According to the most recent rating by Gabelli & Co., on December 11, the current rating is at Hold.
  • Cassava Sciences, Inc. (NASDAQ: SAVA) shares surged 7.9% to $2.05. The market value of their outstanding shares is at $20.6 million.
  • Ocugen, Inc. (NASDAQ: OCGN) shares rose 6.0% to $0.39. The market value of their outstanding shares is at $19.7 million. According to the most recent rating by H.C. Wainwright, on December 20, the current rating is at Buy.
  • Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) stock increased by 4.1% to $0.43. The market cap seems to be at $43.0 million. The most recent rating by H.C. Wainwright, on October 28, is at Buy, with a price target of $1.20.
  • Nabriva Therapeutics, Inc. (NASDAQ: NBRV) shares moved upwards by 4.1% to $1.79. The market cap stands at $158.2 million.
  • Acasti Pharma, Inc. (NASDAQ: ACST) shares rose 3.5% to $2.65. The market cap stands at $158.4 million. The most recent rating by B. Riley FBR, on November 18, is at Buy, with a price target of $8.00.
  • DBV Technologies, Inc. (NASDAQ: DBVT) stock moved upwards by 3.4% to $9.74. The market cap stands at $676.0 million. The most recent rating by Citigroup, on December 16, is at Buy, with a price target of $14.00.
  • SmileDirectClub, Inc. (NASDAQ: SDC) stock increased by 3.3% to $8.83. The market cap stands at $4.4 billion. The most recent rating by Goldman Sachs, on December 18, is at Neutral, with a price target of $10.00.
  • Inovio Pharmaceuticals, Inc. (NASDAQ: INO) shares surged 3.2% to $3.55. The market cap seems to be at $210.9 million. The most recent rating by Roth Capital, on December 19, is at Buy, with a price target of $13.00.
  • Agile Therapeutics, Inc. (NASDAQ: AGRX) shares increased by 2.6% to $2.36. The market cap seems to be at $71.1 million.
  • Exicure, Inc. (NASDAQ: XCUR) shares moved upwards by 2.5% to $2.86. The market cap stands at $256.8 million. The most recent rating by Guggenheim, on November 20, is at Buy, with a price target of $9.00.
  • resTORbio, Inc. (NASDAQ: TORC) shares rose 2.4% to $1.27. The market cap seems to be at $43.7 million. The most recent rating by Cantor Fitzgerald, on November 15, is at Neutral, with a price target of $3.00.
  • Onconova Therapeutics, Inc. (NASDAQ: ONTX) stock rose 2.2% to $0.32. The market value of their outstanding shares is at $4.3 million.
  • Aquestive Therapeutics, Inc. (NASDAQ: AQST) stock moved upwards by 2.2% to $5.56. The market value of their outstanding shares is at $96.1 million. The most recent rating by Wedbush, on December 17, is at Outperform, with a price target of $34.00.
  • Smith & Nephew, Inc. (NYSE: SNN) shares rose 1.9% to $47.83. The market value of their outstanding shares is at $18.6 billion. According to the most recent rating by Bernstein, on November 12, the current rating is at Outperform.
  • Macrogenics, Inc. (NASDAQ: MGNX) stock moved upwards by 1.8% to $11.16. The market cap seems to be at $463.2 million. The most recent rating by Cantor Fitzgerald, on December 19, is at Overweight, with a price target of $17.00.
  • Cronos Group, Inc. (NASDAQ: CRON) shares moved upwards by 1.6% to $7.03. The market value of their outstanding shares is at $2.3 billion. The most recent rating by Bank of America, on November 13, is at Buy, with a price target of $15.00.
  • Correvio Pharma, Inc. (NASDAQ: CORV) shares moved upwards by 1.5% to $0.37. The market cap seems to be at $101.2 million. According to the most recent rating by H.C. Wainwright, on December 11, the current rating is at Neutral.
  • AstraZeneca, Inc. (NYSE: AZN) shares surged 1.2% to $50.57. The market cap stands at $126.9 billion. The most recent rating by Cowen & Co., on December 02, is at Outperform, with a price target of $55.00.

 

Losers

  • Abeona Therapeutics, Inc. (NASDAQ: ABEO) shares decreased by 28.0% to $3.60 during Friday's pre-market session. The market cap seems to be at $120.9 million.
  • CymaBay Therapeutics, Inc. (NASDAQ: CBAY) shares plummeted 10.8% to $1.66. The market cap stands at $308.4 million. According to the most recent rating by Raymond James, on November 26, the current rating is at Market Perform.
  • Catalyst Biosciences, Inc. (NASDAQ: CBIO) shares plummeted 5.3% to $7.49. The market cap seems to be at $65.5 million.
  • Kadmon Holdings, Inc. (NYSE: KDMN) shares declined 3.9% to $4.50. The market cap seems to be at $374.6 million. The most recent rating by Cantor Fitzgerald, on November 12, is at Overweight, with a price target of $10.00.
  • Bionano Genomics, Inc. (NASDAQ: BNGO) shares plummeted 1.9% to $1.03. The market cap stands at $20.9 million.
  • Solid Biosciences, Inc. (NASDAQ: SLDB) shares decreased by 1.4% to $4.10. The market value of their outstanding shares is at $508.2 million. The most recent rating by Nomura, on December 19, is at Buy, with a price target of $10.00.
  • Aurora Cannabis, Inc. (NYSE: ACB) stock plummeted 1.1% to $2.25. The market cap stands at $2.6 billion. The most recent rating by Piper Jaffray, on October 22, is at Neutral, with a price target of $4.00.
 

Related Articles (ABEO + ACB)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Mkt MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com